EMA Guidance on Trial Mgmt during COVID-19
Health Care, Pharma Industry, Strategic Planning
The impact of COVID-19 on ongoing trials, on opening a new trial site in an existing trial, ongoing recruitment and continued involvement of participants in the trial, or on starting of new trials needs to be considered. Read this EMA Guidance to learn more about managing your clinical trials during this pandemic.
Related Education Resources.
All ResourcesEAP 105: Expanded Access Logistics
Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning
Presentation
Members
Current Challenges in Cell and Gene Therapy
Topic: Regulatory
Webinar
Free
Demand Forecasting and the Management of IRT
Topic: Technology
Webinar
Free
